Edition:
United States

PerkinElmer Inc (PKI.N)

PKI.N on New York Stock Exchange

78.40USD
19 Jul 2018
Change (% chg)

-- (--)
Prev Close
$78.40
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
164,721
52-wk High
$84.42
52-wk Low
$62.43

Chart for

About

PerkinElmer, Inc. is a provider of products, services and solutions to the diagnostics, research, environmental, industrial and laboratory services markets. The Company operates through two segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment serves the environmental, food,... (more)

Overall

Beta: 0.88
Market Cap(Mil.): $8,511.10
Shares Outstanding(Mil.): 110.63
Dividend: 0.07
Yield (%): 0.36

Financials

  PKI.N Industry Sector
P/E (TTM): 34.26 37.53 33.05
EPS (TTM): 2.29 -- --
ROI: 5.67 8.77 13.17
ROE: 10.64 12.58 15.10

UPDATE 1-PerkinElmer raises 2018 forecasts as 1st-qtr profit beats Street

April 30 Laboratory equipment maker PerkinElmer posted a slightly higher-than-expected first-quarter profit on Monday and revised its full-year earnings forecast upward as sales grew in both of its business units.

Apr 30 2018

PerkinElmer first-quarter profit beats Street view

April 30 Laboratory equipment maker PerkinElmer on Monday reported slightly higher-than-expected first-quarter profit and revenue and raised its full-year earnings forecast as sales grew in both of its business units.

Apr 30 2018

BRIEF-PerkinElmer Appoints James Mock As Chief Financial Officer

* PERKINELMER INC - ANDY WILSON WILL REMAIN WITH COMPANY AS AN ADVISOR FOR AN INTERIM PERIOD Source text for Eikon: Further company coverage:

Apr 10 2018

BRIEF-PerkinElmer Collaborates With Helix In Exome Based Personal Genomics

* PERKINELMER COLLABORATES WITH HELIX TO DRIVE INNOVATION IN EXOME-BASED PERSONAL GENOMICS

Apr 10 2018

BRIEF-Perkinelmer Inc Files Prospectus Supplement Related To A Potential Senior Notes Offering‍​

* PERKINELMER INC FILES PROSPECTUS SUPPLEMENT RELATED TO A POTENTIAL SENIOR NOTES OFFERING - SEC FILING‍​‍​ Source text: (https://bit.ly/2q3PNq6) Further company coverage:

Apr 04 2018

BRIEF-RHS Enters Deal For Perkinelmer, Inc To Buy All Shares Of Co For $0.28 Per Share

* ENTERS SCHEME IMPLEMENTATION AGREEMENT FOR PERKINELMER, INC TO BUY ALL SHARES OF CO FOR $0.28 PER SHARE

Feb 25 2018

BRIEF-Perkinelmer Reports‍​ Q4 GAAP Loss Per Share From Cont Ops of $0.35

* Q4 ADJUSTED EARNINGS PER SHARE FROM CONTINUING OPERATIONS $0.97

Jan 25 2018

PerkinElmer profit, 2018 forecast top Wall Street estimates

Laboratory equipment maker PerkinElmer Inc on Thursday reported higher-than-expected fourth quarter sales and profit and issued an initial 2018 earnings forecast that surpassed Wall Street estimates.

Jan 25 2018

UPDATE 1-PerkinElmer profit, 2018 forecast top Wall Street estimates

Jan 25 Laboratory equipment maker PerkinElmer Inc on Thursday reported higher-than-expected fourth quarter sales and profit and issued an initial 2018 earnings forecast that surpassed Wall Street estimates.

Jan 25 2018

PerkinElmer profit, 2018 forecast top Wall Street estimates

Jan 25 Laboratory equipment maker PerkinElmer Inc on Thursday reported higher-than-expected fourth quarter sales and profit and issued an initial 2018 earnings forecast that surpassed Wall Street estimates.

Jan 25 2018

Earnings vs. Estimates